SPHERA FUNDS MANAGEMENT LTD's Q3 2026 13F: 20 new positions, 17 exits
Form 13F-HR for the quarter ended Sep 30, 2026 · filed Nov 16, 2026 · 100 reported positions · accession 0001496201-26-000006
What changed this quarter
| Activity | Security | Weight before | Weight now | Change | Shares | Shares % |
|---|---|---|---|---|---|---|
| Increased | ALNYLAM PHARMACEUTICALS INC (ALNY) | 0.5% | 4.5% | +4.0 pts | +110K sh | +1017% |
| New | ISHARES TR (SOXX) | — | 3.2% | +3.2 pts | +37,000 sh | new |
| Reduced | CYBIN INC (CYBN) | 1.5% | 0.7% | −0.8 pts | −1.23M sh | −76% |
| Exited | INSMED INC (INSM) | 1.8% | — | −1.8 pts | −119K sh | −100% |
| New | META PLATFORMS INC (META) | — | 1.8% | +1.8 pts | +16,200 sh | new |
| Increased | CYTOKINETICS INC (CYTK) | 2.7% | 3.6% | +0.9 pts | +142K sh | +65% |
| New | KLA CORP (KLAC) | — | 1.3% | +1.3 pts | +45,220 sh | new |
| Exited | SOLAREDGE TECHNOLOGIES INC (SEDG 2.25 07/01/29) | 1.1% | — | −1.1 pts | −4M sh | −100% |
| New | ABIVAX SA (ABVX) | — | 1.1% | +1.1 pts | +73,716 sh | new |
| New | PHARVARIS N V (PHVS) | — | 1.1% | +1.1 pts | +230K sh | new |
| New | CAMTEK LTD (CAMT) | — | 1.1% | +1.1 pts | +46,800 sh | new |
| Exited | XENON PHARMACEUTICALS INC (XENE) | 0.9% | — | −0.9 pts | −105K sh | −100% |
| Exited | ZENAS BIOPHARMA INC (ZBIO) | 0.8% | — | −0.8 pts | −231K sh | −100% |
| Reduced | ORIC PHARMACEUTICALS INC (ORIC) | 1.2% | 0.7% | −0.5 pts | −404K sh | −54% |
| Reduced | TOWER SEMICONDUCTOR LTD (TSEM) | 4.0% | 2.9% | −1.1 pts | −23,525 sh | −22% |
| Increased | NOVA LTD (NVMI) | 2.0% | 2.3% | +0.3 pts | +13,875 sh | +55% |
| New | ANNEXON INC (ANNX) | — | 0.8% | +0.8 pts | +1.22M sh | new |
| Increased | IMMATICS N.V (IMTX) | 1.0% | 1.7% | +0.7 pts | +585K sh | +81% |
| Exited | FORTE BIOSCIENCES INC (FBRX) | 0.8% | — | −0.8 pts | −250K sh | −100% |
| Reduced | CELLDEX THERAPEUTICS INC NEW (CLDX) | 1.3% | 0.4% | −0.8 pts | −150K sh | −62% |
| Reduced | BIOGEN INC (BIIB) | 3.0% | 2.6% | −0.4 pts | −20,863 sh | −22% |
| Increased | FIRST TRACKS BIOTHERAPEUTICS (TRAX) | 0.1% | 0.9% | +0.8 pts | +132K sh | +475% |
| Exited | VISTRA CORP (VST) | 0.7% | — | −0.7 pts | −29,450 sh | −100% |
| Exited | TALEN ENERGY CORP (TLN) | 0.7% | — | −0.7 pts | −12,135 sh | −100% |
| Increased | BRIDGEBIO PHARMA INC (BBIO) | 2.6% | 3.1% | +0.5 pts | +66,371 sh | +27% |
| New | TECTONIC THERAPEUTIC INC (TECX) | — | 0.7% | +0.7 pts | +187K sh | new |
| Increased | MADRIGAL PHARMACEUTICALS INC (MDGL) | 1.3% | 2.0% | +0.6 pts | +8,376 sh | +48% |
| Exited | GLOBAL X FDS (CLOU) | 0.6% | — | −0.6 pts | −196K sh | −100% |
| Increased | TENAX THERAPEUTICS INC (TENX) | 0.3% | 0.7% | +0.4 pts | +2.2M sh | +1827% |
| New | CRESCENT BIOPHARMA INC. (CBIO) | — | 0.6% | +0.6 pts | +280K sh | new |
| Exited | BIOCRYST PHARMACEUTICALS INC (BCRX) | 0.6% | — | −0.6 pts | −422K sh | −100% |
| Exited | GENERATE BIOMEDICINES INC (GENB) | 0.6% | — | −0.6 pts | −245K sh | −100% |
| New | ADLAI NORTYE GROUP LTD (ANL) | — | 0.6% | +0.6 pts | +236K sh | new |
| Reduced | ULTRAGENYX PHARMACEUTICAL IN (RARE) | 2.8% | 0.8% | −2.0 pts | −250K sh | −42% |
| Reduced | MINERALYS THERAPEUTICS INC (MLYS) | 5.7% | 5.0% | −0.6 pts | −148K sh | −10% |
| New | Q32 BIO INC (QTTB) | — | 0.6% | +0.6 pts | +449K sh | new |
| New | RAPPORT THERAPEUTICS INC (RAPP) | — | 0.5% | +0.5 pts | +100K sh | new |
| Increased | DISC MEDICINE INC (IRON) | 0.7% | 1.1% | +0.5 pts | +51,200 sh | +81% |
| New | LATIGO BIOTHERAPEUTICS INC (LTGO) | — | 0.5% | +0.5 pts | +192K sh | new |
| New | APPLIED OPTOELECTRONICS INC (AAOI) | — | 0.5% | +0.5 pts | +32,210 sh | new |
| Reduced | HARMONY BIOSCIENCES HLDGS IN (HRMY) | 0.9% | 0.6% | −0.4 pts | −80,900 sh | −46% |
| Reduced | ACADIA PHARMACEUTICALS INC (ACAD) | 1.3% | 0.6% | −0.7 pts | −154K sh | −43% |
| Increased | EVOMMUNE INC (EVMN) | 0.0% | 0.5% | +0.4 pts | +368K sh | +1626% |
| Exited | KODIAK SCIENCES INC (KOD) | 0.5% | — | −0.5 pts | −81,796 sh | −100% |
| Exited | ORMAT TECHNOLOGIES INC (ORA) | 0.4% | — | −0.4 pts | −28,015 sh | −100% |
| Increased | LAM RESEARCH CORP (LRCX) | 1.1% | 1.3% | +0.1 pts | +7,430 sh | +40% |
| Exited | BIOHAVEN LTD (BHVN) | 0.4% | — | −0.4 pts | −164K sh | −100% |
| Exited | CONSTELLATION ENERGY CORP (CEG) | 0.4% | — | −0.4 pts | −9,850 sh | −100% |
| Exited | VERASTEM INC (VSTM) | 0.3% | — | −0.3 pts | −633K sh | −100% |
| Reduced | BIOMARIN PHARMACEUTICAL INC (BMRN) | 2.7% | 2.7% | 0.0 pts | −35,304 sh | −11% |
The 50 largest of 101 changes, by size of the trade. Full holdings for this quarter.
Reported by the fund in its Form 13F filed with the SEC; holdings are as of the quarter-end report date and may have changed since. For informational purposes only — not investment advice or a recommendation to buy or sell any security. FilingExplorer is not affiliated with or endorsed by this fund. How this brief is compiled
† Security identifier (CUSIP) changed — read as one continuing position, not an exit and a new position:
- CURIS INC (CRIS): 231269309 → 231269408, 98,996 → 39,665 shares (share count changed with the identifier; not shown as a trade)
- TEVA PHARMACEUTICAL INDS LTD (TEVA): 881624209 → M8769Q102, 1.5M → 821K shares (share count changed with the identifier; not shown as a trade)
Top 10 positions — 35.4% of the equity book
Changes in the top 10 this quarter: ALNY entered · SOXX entered · RARE left · COGT left
| # | Security | Weight before | Weight now | |
|---|---|---|---|---|
| 1 | MINERALYS THERAPEUTICS INC (MLYS) | 5.7% | 5.0% | |
| 2 | TEVA PHARMACEUTICAL INDS LTD (TEVA) | 7.3% | 4.9% | |
| 3 | ALNYLAM PHARMACEUTICALS INC (ALNY) | 0.5% | 4.5% | Entered the top 10 |
| 4 | CYTOKINETICS INC (CYTK) | 2.7% | 3.6% | |
| 5 | ISHARES TR (SOXX) | 0.0% | 3.2% | Entered the top 10 |
| 6 | BRIDGEBIO PHARMA INC (BBIO) | 2.6% | 3.1% | |
| 7 | TOWER SEMICONDUCTOR LTD (TSEM) | 4.0% | 2.9% | |
| 8 | SYNDAX PHARMACEUTICALS INC (SNDX) | 3.2% | 2.9% | |
| 9 | BIOMARIN PHARMACEUTICAL INC (BMRN) | 2.7% | 2.7% | |
| 10 | BIOGEN INC (BIIB) | 3.0% | 2.6% | |
| — | ULTRAGENYX PHARMACEUTICAL IN (RARE) | 2.8% | 0.8% | Left the top 10 |
| — | COGENT BIOSCIENCES INC (COGT) | 2.5% | 2.4% | Left the top 10 |
Weights are each position's reported value as a share of the fund's reported equity positions (options and principal-amount holdings excluded).
Option positions (puts and calls)
Reported separately from the positions above. The value a 13F reports for an option is that of the underlying shares, not the option itself.
| Activity | Security | Type | Shares before | Shares now | Reported value |
|---|---|---|---|---|---|
| Exited | BIOGEN INC (BIIB) | Call | 100K | 0 | $0 |
| Reduced | SPDR SERIES TRUST (XBI) | Put | 150K | 75,000 | $11.8M |
| New | ARK ETF TR (ARKG) | Put | 0 | 200K | $10.8M |
| Exited | CYTOKINETICS INC (CYTK) | Call | 100K | 0 | $0 |
| Exited | ISHARES TR (TLT) | Call | 47,000 | 0 | $0 |
| New | CYBIN INC (CYBN) | Call | 0 | 300K | $3.69M |
| New | TREVI THERAPEUTICS INC (TRVI) | Call | 0 | 250K | $3.58M |
| New | RAPPORT THERAPEUTICS INC (RAPP) | Put | 0 | 100K | $3.36M |
| New | CELLDEX THERAPEUTICS INC NEW (CLDX) | Put | 0 | 100K | $3.24M |
| Exited | ABIVAX SA (ABVX) | Put | 20,000 | 0 | $0 |
| New | TECTONIC THERAPEUTIC INC (TECX) | Call | 0 | 100K | $2.33M |
| New | SYNDAX PHARMACEUTICALS INC (SNDX) | Call | 0 | 100K | $1.88M |
| Exited | ORIC PHARMACEUTICALS INC (ORIC) | Call | 100K | 0 | $0 |
| New | ANNEXON INC (ANNX) | Put | 0 | 250K | $1.06M |
| New | ANNEXON INC (ANNX) | Call | 0 | 250K | $1.06M |
| New | DISC MEDICINE INC (IRON) | Call | 0 | 50,000 | $335K |